Real-time fMRI Neurofeedback in Patients With Schizophrenia and Auditory Hallucinations
Real-time fMRI Neurofeedback as a Tool to Mitigate Auditory Hallucinations in Patients With Schizophrenia - R33 Phase
Boston VA Research Institute, Inc.
104 participants
Mar 1, 2022
INTERVENTIONAL
Conditions
Summary
Neurofeedback intervention aimed to regulate the superior temporal gyrus (STG) activation and default mode network (DMN) connectivity as well as to reduce the auditory hallucinations (AH) schizophrenia patients with medication resistant AH.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
the patients will receive real-time feedback from the brain activity of the superior temporal gyrus
the patients will receive real-time feedback from the brain activity of the somato-motor cortex
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05299749